Trial Profile
Cardiac iobenguane [I-123 MIBG] uptake after 3 months of exercise training in patients with heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Heart failure
- Focus Diagnostic use
- 21 Oct 2015 New trial record
- 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology.